Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takehito Shukuya

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Respiratory Investigation|January 15, 2019
Germline mutations in lung cancerTakehito Shukuya, Kazuhisa Takahashi
Juntendo Medical Journal|May 29, 2026
Advances in Pharmacological Treatment of Thoracic MalignanciesTakehito Shukuya, Kazuhisa Takahashi
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2016
Predictive Markers for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Lung CancerTakehito Shukuya, David P Carbone
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[A case of malignant pleural mesothelioma that responded to cisplatin plus pemetrexed rechallenge]Takehito Shukuya, Toshiaki Takahashi, Yukiko Nakamura, et al.
Anticancer Research|April 3, 2020
Hypoxia Inducible Factor-1α Inhibition in Von Hippel Lindau-mutant Malignant Pleural Mesothelioma CellsTakehito Shukuya, Jun Oyanagi, Masakuni Serizawa, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|October 13, 2007
[A case of pulmonary arteriovenous fistula associated with multiple hepatic arterioportal shunts]Takehito Shukuya, Ryo Atsuta, Yoshiteru Morio, et al.
Cancers|July 12, 2025
Current Status of Multimodal Therapy for Oligometastatic Disease, Induced Oligometastatic Disease, and Oligo-Progressive Disease in <i>EGFR</i>-Mutated Non-Small-Cell Lung CancerTaichi Miyawaki, Hirotsugu Kenmotsu, Ryo Ko, et al.
Respirology Case Reports|January 4, 2024
Extrapleural air secondary to idiopathic pulmonary fibrosis-related pneumomediastinumYuichi Nagata, Takayasu Watanabe, Yuki Tanabe, et al.
Cancer Science|March 3, 2023
Real-world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK-positive non-small-cell lung cancerYasushi Goto, Takehito Shukuya, Ai Murata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 23, 2008
[Efficacy of gefitinib according to smoking status in non-small cell lung cancer patients]Takehito Shukuya, Michihiro Hirama, Toshifumi Yae, et al.
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Respiratory Investigation|January 15, 2019
Germline mutations in lung cancerTakehito Shukuya, Kazuhisa Takahashi
Juntendo Medical Journal|May 29, 2026
Advances in Pharmacological Treatment of Thoracic MalignanciesTakehito Shukuya, Kazuhisa Takahashi
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2016
Predictive Markers for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Lung CancerTakehito Shukuya, David P Carbone
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 25, 2010
[A case of malignant pleural mesothelioma that responded to cisplatin plus pemetrexed rechallenge]Takehito Shukuya, Toshiaki Takahashi, Yukiko Nakamura, et al.
Anticancer Research|April 3, 2020
Hypoxia Inducible Factor-1α Inhibition in Von Hippel Lindau-mutant Malignant Pleural Mesothelioma CellsTakehito Shukuya, Jun Oyanagi, Masakuni Serizawa, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|October 13, 2007
[A case of pulmonary arteriovenous fistula associated with multiple hepatic arterioportal shunts]Takehito Shukuya, Ryo Atsuta, Yoshiteru Morio, et al.
Cancers|July 12, 2025
Current Status of Multimodal Therapy for Oligometastatic Disease, Induced Oligometastatic Disease, and Oligo-Progressive Disease in <i>EGFR</i>-Mutated Non-Small-Cell Lung CancerTaichi Miyawaki, Hirotsugu Kenmotsu, Ryo Ko, et al.
Respirology Case Reports|January 4, 2024
Extrapleural air secondary to idiopathic pulmonary fibrosis-related pneumomediastinumYuichi Nagata, Takayasu Watanabe, Yuki Tanabe, et al.
Cancer Science|March 3, 2023
Real-world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK-positive non-small-cell lung cancerYasushi Goto, Takehito Shukuya, Ai Murata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 23, 2008
[Efficacy of gefitinib according to smoking status in non-small cell lung cancer patients]Takehito Shukuya, Michihiro Hirama, Toshifumi Yae, et al.
Pageof 14